Davies Veterinary Specialists (DVS), the private small animal referral centre based in Hertfordshire, has installed two new state-of-the-art ESAOTE ultrasound machines.
DVS says The MyLab Twice Vet and the MyLab Class C Vet provide fast, efficient and highly accurate imaging in a wide range of applications, including high-definition abdominal, cardiac, musculoskeletal and ophthalmic scans.
The MyLab Twice Vet, with its range of probes including the broadband 18MHz linear probe, will be used for general ultrasonographic imaging at DVS. It is capable of the most refined contrast media examinations that, for example, can help to locate and identify a liver tumour that may be rendered invisible when using conventional diagnostic procedures.
The MyLab Class C will be used predominantly for advanced cardiac work, including trans-oesophageal echocardiography for interventional procedures in theatre.
Pedro Oliveira, European Veterinary Specialist in Cardiology at DVS said: "The trans-oesophageal probe is currently a very rare piece of equipment in veterinary diagnostics. It gives us the capacity to obtain unique views of the heart, especially the heart base which can be a very difficult area to examine with regular echocardiography. It also allows real-time and direct monitoring of procedures, such as deployment of devices to occlude patent ductus arteriosus, surgery and anaesthesia in critical patients."
The first patient to benefit from the new My Lab Class C was an 11-year-old, female German shepherd dog with suspected cardiac neoplasia following several episodes of haemorrhage into the pericardium. A normal echocardiographic examination identified a small suspect area but it was in a part of the heart that was very difficult to approach surgically.
However, a trans-oesophageal examination revealed that another small mass close to the tip of the right auricle was actually the origin of the bleeding. The dog underwent surgery to remove the mass and subsequently made a full recovery. Without the My Lab Class C there would have been no viable options for this dog.
Clive Elwood, Managing Director at DVS, said: "Combining the best possible on-site diagnostic equipment with some of Europe's finest clinicians enables us to provide the best possible service and outcome for our patients, across multiple disciplines."
The RCVS Disciplinary Committee has directed that a Leeds-based veterinary surgeon, whose convictions for threatening behaviour, theft, and assault made him unfit to practise, should be removed from the Register.
At the outset of the two-day hearing, Dr Gary Samuel admitted his convictions. These related to his actions near his property in Cardiff on 10 July 2011, and were received at Cardiff Magistrates' Court on 22 November 2011. The Committee was asked to decide if these convictions made Dr Samuel unfit to practise veterinary surgery, and to decide upon any sanction.
The facts of the offences, as set out at the magistrates' court by the prosecution, were that Dr Samuel took a camera and memory card from a neighbour who was taking photographs of construction works behind his property. In doing so, he grabbed the neighbour from behind, twisting her arm, and later threatened her and her partner with a large piece of wood.
Although Dr Samuel wrote to the College saying he had pleaded guilty to the charges, he also denied some of the offences charged, suggesting that it was the neighbour who had been abusive towards him.
The Committee allowed the possibility that Dr Samuel was provoked by the taking of photographs and may have been subjected to offensive abuse by the neighbour, and considered that he acted impulsively and lost control of his actions. However, the convictions were for serious offences: the assault resulted in injury to the victim; the threatening behaviour involved a risk of injury to the victim and her partner; and, the theft involved dishonesty. Dr Samuel's conduct at the time was "reckless", and he had since displayed very limited insight into his behaviour.
Professor Peter Lees, chairing and speaking on behalf of the Committee said: "The Committee considers that the offences of which the Respondent was convicted, and to which he pleaded guilty, were serious, as is reflected in the suspended sentences, community service orders, fines, restrictions and penalties imposed by the court. The Committee accepts that this is not a case in which the welfare of animals has been put at risk, but takes the view that a serious sanction is required in order to uphold the reputation of the veterinary profession, and public confidence in it, and to uphold proper standards of conduct and behaviour on the part of its members."
The Committee directed Dr Samuel's name should be removed from the Register.
Ceva Animal Health has launched a new TV advertising campaign designed to raise awareness of problems owners may face in a multi-cat environment.
The Cat Cabin Fever campaign will run for four weeks.
Ceva says the 20 second TV ads have been designed to strike a chord with viewers who have more than one cat in their household, where 'sometimes sharing just isn't an option'. Highlighted in particular is the Feliway Diffuser which releases natural pheromones into a room to help cats feel at ease, allowing them to cope with stressful situations and prevent unwanted behaviour. Malcolm Laurie, head of marketing at Ceva, said: "We know that there are more than 8million cats in the UK and only 2.5million cat households, therefore the majority of households must have more than one cat. "However, cats are solitary animals, which makes living with other cats difficult at times. This campaign is focused on making the lives of cat owners and their pets as harmonious as possible, including lots of top tips on how to ease any tensions in such an environment." Ceva has also produced a multi-cat leaflet designed to give owners specific advice on how to provide the correct environment for our feline friends The advertising campaign will be supported by online competitions, marketing materials for veterinary clinics and retailers, which include a checklist for a cat friendly home, and PR. For more information, visit: http://www.feliway.co.uk/.
Bimeda has announced the UK launch of Selenate LA, for selenium deficiency in calves and adult cattle.
Bimeda's Head of Technical Services, Padraig Hyland MVB said: "The slow release product provides raised selenium levels for a full 12 month period. When injected, Selenate LA forms a reservoir under the skin and its low solubility sees an even release of selenium over a year. But it's not just the efficacy of Selenate LA that make it such a stand out product, it's the convenience too".
Bimeda says the health properties of Barium Selenate in selenium deficient herds are well documented, from prevention of white muscle disease, anoetrus and mastitis, to improved conception rates and milk yield¹.
However there are various choices for farmers when dealing with selenium deficiency.
Padraig said: "The beauty of Selenate LA is that it is one injection, once a year. You know exactly how much each cow is getting so it's very predictable. And with many farmers already time short, it makes selenium supplementation extremely straightforward and cost effective."
Selenate LA is a POM-V medicine and can be offered by veterinary surgeons based on serum levels of glutathione peroxidase from a representative sample of the herd, or as part of a herd health and fertility plan. Padraig said: "It allows vets to offer a cost-effective and licensed alternative to oral supplements, with the added piece of mind only an injection can bring.
"The long-lasting and effective levels of selenium allow injection of the dam at any time, including mid to late pregnancy, to ensure good selenium levels in the new-born calf. This also prevents those post-calving complications such as retained foetal membranes, metritis and poor calving to conception times, where selenium deficiency has been implicated".
The company confirms that there is no milk withdrawal period and a thirty one day meat withdrawal for the product. Selenate LA is administered via a subcutaneous injection from a multi-dose bottle. For further information contact Andrew Lane, Bimeda UK Sales Manager on 07917 208524.
References
1. 1987 (Taranaki, North Island)
The Animal Health Trust's (AHT) Dr Sue Dyson has been awarded a place in the International Equine Veterinarians Hall of Fame, in recognition of her contribution to hoof care in horses.
Sue, who is Head of Clinical Orthopaedics at the AHT, has lectured internationally and is known for both her clinical work with horses and an extensive research record, having published more than 200 refereed papers on lameness and diagnostic imaging in scientific journals. She has also co-authored several veterinary textbooks as well as training and competing as a high-level rider in international events.
Established in 1997, the International Equine Veterinarians Hall of Fame honours veterinary surgeons who have contributed to the knowledge and recognition of proper hoof care for horses. Vets are nominated either as practicing equine vets who work closely with farriers in the field, or as college and industry vets involved in teaching, research or other important aspects of equine veterinary and hoof care.
Anyone can nominate an equine vet for the award, which is sponsored by the American Farriers Journal, but selection is completed by previous inductees into the International Equine Veterinarians Hall of Fame. Awards are presented each year during the International Hoof-Care Summit in Cincinnati, Ohio.
Sue said: "I was completely surprised, but absolutely thrilled, to learn that I had been selected to join the distinguished list of people who have previously been appointed to the International Equine Veterinarians Hall of Fame.
"I think it is very humbling to recognise that, despite the knowledge that my team and I have amassed in the last 30 years, there is so much more to learn. From every new finding come many more questions. I hope that the enthusiastic dedication of my team will continue to result in learning and discovering more, and inspire others to do likewise, to the ultimate benefit of the welfare of our great friend, the horse."
Sue has has worked at the AHT for 30 years and is currently researching the association between hindlimb lameness and saddle slip. She has observed some association between the two for several years, however saddle slip has traditionally been attributed to an ill-fitting saddle, asymmetry of the horse's back shape or a crooked rider.
In 2011 Sue carried out a prospective research project with Intern Line Greve: 'Saddle slip may be an indicator of the presence of hindlimb lameness'. It was presented at the 51st Annual Congress of the British Equine Veterinary Association, Birmingham 2012, and identified that in some cases, saddle slip was directly linked to the presence of hindlimb lameness.
Research results showed that of 128 horses assessed for lameness grade and degree of saddle slip when ridden by two riders, the saddle consistently slipped to one side in 54% of the horses with hindlimb lameness, in comparison to just 4% of the horses with forelimb lameness. Diagnostic analgesia to abolish the hindlimb lameness eliminated the saddle slip in 97% of the horses observed in the study.
Sue and Line are currently undertaking further research to measure movement of the back, and forces under the saddle, with the aim of explaining biomechanically what is happening during the occurrence of saddle slip.
The RCVS Disciplinary Committee has refused an application for restoration to the Register by Mr Joseph Holmes, who was struck off in 2011 for serious professional misconduct associated with surgery he had carried out on a dog and two cats.
At a two-week Disciplinary Committee hearing that concluded on 14 January 2011, two separate complaints had been considered against Mr Holmes, formerly of Waltham Veterinary Clinic, Grimsby. These involved a total of 31 charges, of which 28 were found to amount to serious professional misconduct. Mr Holmes was found to have advised on and undertaken surgical procedures without sufficient clinical grounds or consideration of alternative treatment options; failed to obtain the informed consent of his clients; undertaken procedures outside his area of competence; failed to refer or discuss the option of referral to a specialist; and, failed to provide his patients with adequate pain relief.
The then-Committee directed Mr Holmes' name be removed from the Register, whereupon he appealed to the Privy Council, who dismissed his appeal on 22 December 2011, concluding that removal from the Register "was the only disposal which could properly reflect the primary need to serve both the interests of animal welfare and the reputation of the veterinary profession".
At the hearing last week the Committee considered several factors in relation to Mr Holmes' application for restoration. Although Mr Holmes gave assurances that he accepted the findings of the original hearing, this contrasted completely to the robust way in which he had challenged all of these at that hearing and the majority in his appeal. Mr Holmes had been off the Register for only 12 months - just over the minimum period before an application for restoral was permitted. The Committee took the view that the application was premature and was not satisfied that Mr Holmes truly appreciated the seriousness of the findings made against him.
In response to questions from the Committee, Mr Holmes showed deficiencies in his knowledge, such as not knowing all of the constituents of the human drug, Anadin Extra, in spite of having produced a record of continuing professional development (CPD) on analgesia and having prescribed it to a dog in the original complaint. He did not provide records of CPD for 2010, 2011 and 2012, and although recognising that working in isolation from the majority of his fellow practitioners had contributed to his failures, he had made very limited efforts to observe first-opinion veterinary practice.
The Committee accepted at face value Mr Holmes' statement that he had not worked as a veterinary surgeon whilst de-registered, and accepted that removal from the Register had had a profound effect on Mr Holmes and his family, including the sale of his practice. It noted that Mr Holmes produced only the testimonials previously submitted to the Privy Council, which were of limited scope.
Professor Peter Lees, chairing and speaking on behalf of the Committee said: "Having regard to all the factors set out above, the Committee regrets that it is not satisfied that the applicant is fit to be restored to the Register. Accordingly, the application is refused."
Vetoquinol - makers of the NSAID Cimalgex - has announced the launch of its updated website www.CiMyDog.co.uk.
The company says the website has been developed to provide reliable online information about pain in dogs to cater for the increasing needs of pet owners and vets.
The website has two sections. The first is a pet owner focussed, educational tool which takes the visitor on a journey through the process of pain; from spotting the signs of pain all the way through to ways of relieving pain, culminating in the recommendation that the visitor seeks advice from their veterinary practice.
The second section requires registration as it contains more in depth information on the pain process and potential treatment options available, this section is for veterinary professionals only. Also on this section of the website there are many scientific abstracts related to pain and treatment with links to enable the veterinary visitor can view this peer reviewed material.
Robert Simpson, Cimalgex Product Manager said: "The internet is a very powerful tool in terms of increasing education, especially in areas such as canine pain. Unfortunately there can also be a lot of misinformation online and so we felt it was important for Vetoquinol to try and redress the balance by producing www.CiMyDog.co.uk. This can be used as a reliable and up-to-date resource by pet owners and veterinary professionals alike. -
www.CiMyDog.co.uk is a very interactive site which aims to demystify the pain treatment process, ensure pet owners look out for behavioural signs of pain and looks to improve overall canine health with assistance from their veterinary practice. We hope that this will be a valuable resource to which vets can refer their pet owners."
A new study1 published in the Equine Veterinary Journal's (EVJ) special American Association of Equine Practitioners supplement has concluded that maggots can play an integral role in modern veterinary care for a variety of wounds in horses.
The study assessed the efficacy of maggot debridement therapy in a diversity of equine lesions and found that the method was beneficial in 93% of cases.
Maggots have been used for the treatment of wounds for hundreds of years. Freshly emerged, germ-free larvae of the common green bottle fly are usually used for the purpose. Their wound-healing action is attributed to a debridement effect, an antiseptic effect, a direct effect on cytokine and cell proliferation involved in wound healing and breakdown of biofilm formation. Maggots also destroy and digest bacteria and may also be beneficial in the fight against multi-drug-resistant bacteria such as MRSA.
The study involved the retrospective analysis of 41 horses with various lesions including foot injury, limb laceration, soft tissue abscesses and musculoskeletal infection. Depending on the type, size and location of the wound the maggots were applied either in direct or indirect contact. In some cases a second maggot application was necessary to reach the desired level of healing. Debridement, disinfection and healing occurred in all but three cases, in less than a week. Of the three that did not respond two were complicated by the presence of tumours and one by pre-existing damage to the underlying bone.
Olivier Lepage of the University of Lyon, who led the study, said: "These results show that maggot debridement therapy potentially has an integral place in modern veterinary wound care. It can be used to treat many types of lesions, although not those involving tumours or bone sequestration. Associated high costs present a limiting factor but maggot debridement therapy should certainly be considered for lesions that fail to respond to conventional methods."
Professor Celia Marr, Editor of the EVJ, said: "Horses often suffer from non-healing wounds, particularly in the limbs where the skin is under continuous movement and there is very little subcutaneous tissue. Although at first glance this study might seem counter-intuitive and we might think of maggots as being the last thing one would want on a clean wound, it shows that maggots can be an effective way to clear damaged tissue and this is an important adjunctive approach in equine wound management."
1The use of maggot debridement therapy in 41 equids OM Lepage, A Doumbia, MF Perron-Lepage and M Gangl. EVJ ISSN 0425-1644 DOI: 10.1111/j.2042-3306.2012.00609.x
The study is published by Wiley-Blackwell and can be accessed at http://onlinelibrary.wiley.com/doi/10.1111/j.2042-3306.2012.00609.x/abstract
The RCVS Disciplinary Committee has reprimanded a veterinary surgeon for submitting a certificate of Clinical Inspection for Veterinary Inspectors ("TB52") for tuberculin tests he had undertaken on cattle, despite knowing that he had not fully complied with the standard operating procedures (SOP) for these tests.
At the outset of the three-day hearing, John Wilson admitted that, when acting as an Official Veterinarian (OV) he had not carried out tuberculin tests on cattle at a Wiltshire farm on 19 May 2011 strictly in accordance with the SOP required by the Animal Health and Veterinary Laboratories Agency (AHVLA), an executive agency of Defra.
The admitted shortcomings were that on 19 May, the second day of testing, Mr Wilson had failed to confirm the identity of all the animals, failed to inspect the animals digitally (ie using his hands) and had not measured the fold of skin at the injection site of all the animals. The College argued that this was contrary to the directions of the AHVLA and, in subsequently signing the TB52 certificate, he was either dishonest or should have known that the certification was incorrect. Mr Wilson admitted that he ought to have known the certification was incorrect but denied dishonesty, because he believed that he had conducted the test in a satisfactory manner and had correctly identified all the reactors in the herd.
Mr Wilson was a veterinary surgeon of over 40 years experience and unblemished record, and the Committee found his account of events to be accurate and honest. He said the farm involved was unprepared and test arrangements were chaotic, with poor handling facilities, and he would have been concerned for the safety of the animals and their handlers if he had complied fully with the SOP. He had advised the farmer to delay the test but his advice was rejected.
The Committee accepted that the testing had been carried out under exceptional and difficult circumstances. It noted that Mr Wilson had identified a reactor and taken appropriate actions, knowing that the outcome would be the quarantining of the whole herd. He had made no financial or other gain, other than the nominal fee charged for the work. Although failing to comply with the SOP fell short of what was expected of a veterinary surgeon, because of these circumstances, and as he had acted in what he considered to be the best interests of the animals and personnel, these actions did not amount to serious professional misconduct.
The Committee found that, even allowing for these difficulties and concerns, in signing the TB52 certificate a few days later, without any qualification, Mr Wilson ought to have known that it was incorrect, and his actions fell far short of the standards expected of the veterinary profession. They did not however find that he had been dishonest.
The Committee stressed the importance attached to accurate and reliable certification, in maintaining the confidence of the public and the profession, and in ensuring animal welfare.
Professor Lees, chairing and speaking on behalf of the committee said: "The Committee is aware, as confirmed by AHVLA, that this is a single, isolated event and the first offence in some 40 years of the Respondent working as a LVI [local veterinary inspector] or OV. After considering all the mitigating factors.and, given the exceptional circumstances of this specific case, the decision of the Committee is to reprimand Mr Wilson."
The RCVS is to hold an online hustings on Tuesday, 19 March at 7pm to help voters decide who they wish to vote for in the upcoming RCVS Council elections, and is inviting members of the veterinary profession to suggest questions for the candidates to answer.
Gordon Hockey, RCVS Registrar said: "From feedback we've received, one of the reasons why people don't vote is because they know little about the candidates or their views. We hope this hustings will provide the candidates with a platform to address the veterinary electorate directly, and give voters the chance to put their own questions to those hoping to serve on Council."
The hustings will be run as a live webinar by 'The Webinar Vet' and will be free to listen to. However, the College says that due to the high number of candidates standing for election, it isn't possible to hold a debate, so questions should be submitted in advance (see below). Each candidate will be allocated around three minutes to introduce themselves and answer up to three questions of their choosing. The whole event will run for just under an hour.
Anthony Chadwick, who runs The Webinar Vet, will moderate proceedings, and Gordon Hockey will be on-hand to address any factual inaccuracies.
Veterinary surgeons can register to listen to the hustings at www.thewebinarvet.com/rcvs and submit their questions at the same time; alternatively, questions can be emailed to Ian Holloway at the RCVS (i.holloway@rcvs.org.uk).
Questions should be relevant to the role of the RCVS and the role of Council Members (see www.rcvs.org.uk/about). If questions should remain anonymous, please say so.
Ballot papers and candidates' biographies and manifestos are due to be posted on 7 March. Votes may be cast online, by text message or by post, by 5pm on Friday, 26 April 2013.
Elanco Companion Animal Health has launched of Dexdomitor 0.1 mg/ml, adding to its range of alpha-2 agonists and antagonists.
Produced and manufactured in partnership with Orion Corporation, Elanco says Dexdomitor 0.1 mg/ml contains all the properties of dexmedetomidine in a formulation that allows accurate and convenient dosing for the smallest patients. It can be used as a sedative for non-invasive, mild to moderately painful procedures and examinations which require restraint, sedation and analgesia in dogs and cats. It can also be used for deep sedation and analgesia in dogs in concomitant use with butorphanol for medical and minor surgical procedures and as a pre-medication in dogs and cats before induction and maintenance of general anaesthesia.
Dexdomitor 0.1 mg/ml has been designed to provide accurate dosing in very small dogs (up to 5kg) for sedation and pre-medication, small to mid-size dogs (up to 20kg) for pre-medication, and small cats (up to 3kg) for sedation and pre-medication.
Ed Whittle MRCVS, technical consultant at Elanco Companion Animal Health said: "With nearly a quarter of dogs weighing less than 6kg and nearly three-quarters weighing less than 23.1kg1, Dexdomitor 0.1mg/ml is ideal for small animals that require low concentration doses of dexmedetomidine for convenient and accurate dosing".
Elanco has has also produced a sedation and pre-medication dosing guide to educate veterinary professionals on the recommended doses for its range of alpha-2 agonists and alpha-2 antagonists.
For further information contact your Elanco Companion Animal Health key account manager or email elancoCAH.uk@elanco.com.
The PDSA has announced the launch of a new graduate programme to help train the veterinary surgeons of the future.
Applications for PDSA's Veterinary Surgeon Graduate Programme open today, and the programme is open to all veterinary surgeon graduates - including the current 2013 graduating student cohort.
According to the PDSA, its Veterinary Surgeon Graduate Programme is one of the first comprehensive - UK wide - graduate schemes in the veterinary profession to combine clinical experience, development of surgical skills, promotion of preventive services and pet wellbeing education. It is delivered via a structured programme with dedicated support including mentoring, training and continuing professional development opportunities - within a busy small animal charity practice environment.
Following the framework of the Royal College of Veterinary Surgeons (RCVS) Professional Development Phase (PDP), the duration of the programme is one year. Successful applicants will be based at one of five PDSA PetAid hospitals - Glasgow East, Bradford, Liverpool Kirkdale, Stoke-on-Trent or Bow - and will also work at several other PDSA PetAid hospitals within the geographic location, building up experience in different hospitals and working with different teams. There will also be dedicated time off the veterinary rota to be able to train and coach the new graduates to develop their clinical skills.
The charity says that the programme will provide the necessary experience for new graduates to complete their compulsory PDP. It is hoped that those successfully completing the graduate programme will continue their careers with PDSA taking on available permanent opportunities in the charity.
Richard Hooker, PDSA Director of Veterinary Services (pictured above left), said: "At PDSA, we have great talent within our veterinary teams and we are looking to add to that even further with the launch of our Veterinary Surgeon Graduate Programme; five outstanding graduates will join us in September 2013 to be part of PDSA's future and to develop their skills and experience as veterinary surgeons.
"On average, our PetAid hospitals see around 5,695 pets each working day - including consultations, emergency treatment, surgical procedures, through to preventative measures and education on pet wellbeing. The Veterinary Surgeon Graduate Programme will give our cohort the opportunity to gain invaluable small animal practice with the UK's leading veterinary charity, home to some of the most experienced and long-serving vets in our profession."
Applications are open until 29 March 2013. For further information and to apply, visit http://www.pdsa.org.uk/careers/graduate-programme/veterinary-graduates/apply-now or contact PDSA at hr.adminstration@pdsa.org.uk
Dr. Tracy Hill, a specialist in internal medicine, has joined the Royal (Dick) School of Veterinary Studies, bringing with her expertise in interventional radiology.
Tracy completed a fellowship in interventional radiology and endoscopy at the Animal Medical Centre in New York, will be researching new techniques in this developing field.
She will also work in the clinic at the School's Hospital for Small Animals and as a senior lecturer.
She said: "Interventional radiology is an emerging and expanding area in veterinary medicine. Interventional radiology employs the use of fluoroscopy and endoscopy to enable minimally invasive treatments for diseases in many body systems. These techniques often reduce morbidity, mortality, or cost associated with more invasive procedures. The Dick Vet has been performing interventional cardiac procedures for some time and we are looking to expand this field into treatment of non-cardiac diseases."
Tracy, who carried out her residency in small animal internal medicine at North Carolina State University, where she also completed a PhD, will help the Royal (Dick) School of Veterinary Studies at the University of Edinburgh to provide interventional radiology procedures.
This includes a minimally invasive treatment for certain liver shunts using a procedure only being regularly performed at a handful of veterinary hospitals in the world. In this procedure, fluoroscopic guidance is used to access the abnormal vessels in the abdomen via a catheter placed in the jugular vein in the neck. The abnormal shunt vessel is then closed using coil embolization, without the need for abdominal surgery.
Tracey said: "I am delighted to join the Dick Vet. There is no denying the expertise at the vet school, as well as its partnership with The Roslin Institute for research."
Boehringer Ingelheim has announced that its 'Talk About Laminitis' campaign will run from Mid March until the end of June.
Last year, the initiative saw over 9000 horses and ponies tested for PPID through its free ACTH test scheme. This year, to build on this success and support the testing of even more animals, the company has announced a high impact, co-ordinated campaign to drive awareness that up to 90% of laminitis cases may have an underlying endocrine cause1,2.
Once again, Boehringer is urging veterinary surgeons to carry out free ACTH blood tests on laminitic or foot-sore horses as part of the campaign, which is backed by Redwings, The British Horse Society and World Horse Welfare.
Professor Andy Durham from the Liphook Equine Hospital, where the ACTH tests are performed, said: "We are learning so much from these tests. For example, we are now recognising PPID routinely in laminitic horses and ponies as young as 10 years old, and in the spring when we might expect to see more EMS cases, where veterinary surgeons have also tested for PPID we are seeing both abnormally elevated ACTH and insulin. Unless the PPID is addressed, horses will continue to be at risk of painful recurrent laminitic episodes which is a significant welfare issue to the horse and extremely frustrating for owners."
To participate in the scheme, veterinary surgeons and horse owners can download ACTH blood test vouchers from www.talkaboutlaminitis.co.uk. Attach the voucher to the ACTH sample submission form and the ACTH laboratory fees will not be charged.
Lee Hackett from The British Horse Society said: "Without the 'Talk About Laminitis' initiative and the support of Boehringer Ingelheim, literally thousands of horses may not be receiving the appropriate treatment and management for their laminitis to help prevent recurrence. We hope as many veterinary surgeons as possible get involved this year to continue this welfare success."
To ensure that horse owners are fully aware of the initiative, a PR and advertising campaign in the equine consumer media will start in March. The ad campaign includes an infomercial on Horse & Country TV (SKY Channel 280), with viewer numbers in excess of 450,000 per month.
There will also be a live online broadcast for horse owners on endocrinopathic laminitis presented by David Rendle BVSc MVM CertEM(IntMed) DipECEIM MRCVS, from the Liphook Equine Hospital in Hampshire. The one-hour webinar, which takes place at 8.00pm on Wednesday 10 April, will educate horse owners on how the veterinary profession's understanding of this debilitating and devastating disease has been completely revolutionised over the past five years. It will be followed by an interactive Q&A session when viewers will be able to pose questions for David to answer.
David said: "As our knowledge of the two hormonal diseases responsible for the majority of cases of laminitis improves, veterinary surgeons can offer their clients more comprehensive advice on treatment options to prevent laminitis. For many owners who have struggled with this condition, this is an absolute revelation and has enormous welfare benefits".
Horse owners can register to view the online programme by visiting www.talkaboutlaminitis.co.uk.
To ensure that veterinary surgeons are versed in the most up to date research available, Boehringer Ingelheim will also be hosting a webinar for veterinary professionals at 8.00pm on Wednesday 13th March, presented by Professor Andy Durham BSc BVSc CertEP DEIM DipECEIM MRCVS. The online seminar, 'The laminitis revolution.... An update on our understanding of endocrinopathic causes of laminitis', will entitle the viewer to a downloadable certificate for one hour of CPD. To register, visit www.bi-academy.co.uk. Places are limited, so register early to avoid disappointment. The webinar will also be available to view after the event on demand.
For further information on how you can promote 'Talk About Laminitis' in your practice contact your Boehringer Ingelheim Territory Manager or call 01344 746959
1. Karikoski et al. (2011). The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. Domestic Animal Endocrinology 41 111-117
2. Donaldson et al. (2004). Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. J Am Vet Med Assoc;224:1123-1127.
A study published by Mike Dryden - one of the world's leading parasitologists - in Veterinary Parasitology has demonstrated that spinosad (Comfortis, Elanco) provides a high level of flea control one month after a single treatment and maintains a high level of effectiveness under conditions of natural challenge following subsequent monthly treatments.
The multi-clinic, investigator-blinded study1 was undertaken in client-owned dogs provided with three consecutive monthly treatments of oral spinosad (SPN) and fipronil/methoprene spot-on (FSM). All other household dogs and cats, to a maximum of four pets per household, were dispensed the same treatment. Subsequent treatments were given when the dog returned for whole-body flea counts and pruritus-scoring on days 30 and 60, with final assessments on day 90 (plus/minus five days on each occasion).
One hundred and twenty eight dogs were enrolled on the study at 10 veterinary practices in the USA (65 in the SPN arm and 63 in the FSM arm). On day 0, mean flea counts were 57.7 (range: 10-1469) and 44.8 (range: 10-717) for the SPN and FSM groups, respectively. On day 90, 55 of the 58 (95%) SPN dogs were flea free compared with only 21/55 or 38% of dogs in the FSM group. Mean pruritus scores declined to 0.92 (6.67 on day 0) in the SPN group and 3.83 (6.33 on day 0) in the FSM group by day 90. Mean flea counts were 0.08 and 5.19 for SPN and FSM groups respectively on day 90 correlating to a reduction in flea counts of 99.9% in the SPN dogs and 88.4% in the FSM dogs. Between treatment differences were found to be highly statistically significant (p<0.0001) for every parameter measured at every time point during the study in favour of SPN.
Anna Jackson, national veterinary manager for Elanco Companion Animal Health said: "The recent study confirms oral spinosad's outstanding efficacy in controlling fleas and associated pruritus in dogs when administered by owners following natural challenge in the home environment".
For further information please contact your local Elanco Companion Animal Health key account manager or phone 01256 353131.
1 Assessment of owner-administered monthly treatments with oral spinosad or topical spot-on fipronil/(S)-methoprene in controlling fleas and associated pruritus in dogs. Michael W. Dryden, William G. Ryan, Margie Bell, Anthony J. Rumschlag, Lisa M. Young, Daniel E. Snyder. Veterinary Parasitology 191 (2013) 340-346
Kruuse has announced the launch of two new two new wound dressing products: Kruuse HydroGel and Kruuse Foam Dressing.
Kruuse HydroGel is a clear amorphous hydrogel with Polyhexanide (0.04%). According to the company, HydroGel will help maintain a moist healing environment encouraging autolytic debridement and gentle removal of slough and necrotic tissue. It is presented as a single dose 15g applicator tube.
KRUUSE Foam Dressing is a non-adhesive; absorbent hydrophilic foam wound dressing coated with bacterial resistant micro porous thin foam backing. The company says it 'breathes' to allow oxygen in, expands as it absorbs exudate and conforms to shallow wound cavities. It is presented in 3 sizes: 5x5cm, 10x10cm and 15x15cm.
Andrew Groom , Managing Director, Kruuse UK Ltd. said: "Both products enhance the Kruuse's wound care product portfolio available to all customers, combined they increase the already extensive range of wound products available to the veterinary practitioner".
Both products will be on dispay and available at BSAVA 2013.
Ceva Animal Health has launched its 2013 ReprodAction desktop calendar, with a droll take on cycling cows.
The calendar is available free of charge to vet practices.
If you haven't received your calendar yet, contact Ceva Animal Health on 01494 781510 or email cevauk@ceva.com.
Life Technologies has announced the launch of a new ELISA test for bluetongue virus (BTV) antibodies.
According to the company, studies have confirmed that the LSI VET Ruminant Bluetongue II-serum ELISA can detect antibodies to BTV in experimentally infected sheep after 6 days, and in cattle after 7-8 days - several days sooner than some other commercially available test kits, including the company's previous ELISA test which the new product has replaced.
Life Technologies asked the UK's Pirbright Institute, the European Union Reference Laboratory for BTV, to conduct a preliminary assessment of the new test. The new test was able to detect antibodies in all 24 BTV reference sera and BTV 26 held by Pirbright, and showed high sensitivity in a longitudinal study of experimentally infected animals.
The Pirbright study also demonstrated that the LSI VET Ruminant Bluetongue II-serum ELISA could detect BTV antibodies in cattle and sheep that had been vaccinated with an inactivated Bluetongue vaccine.
The new test was developed by Life Technologies Animal Health in its research laboratory near Lyon in France and will be available in EU countries via Life Technologies Animal Health distributors according to local regulatory requirements (see www.lifetechnologies.com/lsi-animal-health) for details.
A survey carried out by Cats Protection has found that around a quarter of Britain's cats (23%) are being fed treats despite the fact that their owners consider them overweight already.
The survey of 1,120 cat owners revealed that 70% of cats described as 'slightly' or 'very overweight' are given a special food treat at least once a week by their owners. 28% of them are being given a special treat at least once a day.
The survey also found that all cats - irrespective of their weight - are fed special treats over Christmas that are not suitable for their health. Nearly 8% feed their cats a special Christmas dinner consisting of human food, whilst some cats are given chocolate (2%) stuffing (2%), and Christmas pudding (1%).
Maggie Roberts, Cats Protection's Director of Veterinary Services, said: "The survey showed that Britain's overweight cats continue to be fed too many treats, which owners principally did out of love, habit or a desire to make their cat feel like a member of the family. However, overweight cats are at significant risk of diabetes and arthritis so there is the danger that owners are making a bad situation even worse.
"The survey also shows that it wasn't uncommon for cats to be given treats such as milk, chocolate or cheese. All of these could make cats quite ill."
National Veterinary Services has announced that from 14th January, veterinary practices will be able to place their daily orders up to 8pm, 7 days a week.
The veterinary wholesaler will also be providing a telephone ordering service on Saturday mornings from 9am until 12pm.
Martin Riley, NVS Managing Director said: "We are always keen to understand practice needs and to deliver on their requests. This is a significant change for the industry and with the introduction of more new tools and services later in the year we believe NVS will make a great difference to our customers."
For further information please contact 01782 770319.
Norbrook Laboratories Ltd has launched the 2013 - 2014 edition of its UK Veterinary Surgeon's Product Compendium.
The compendium contains data sheets for the complete range of over 120 Norbrook products which are available in the UK and Northern Ireland, including 17 new products which have been launched since the last compendium was issued.
The compendium is available from your Norbrook representative or can be downloaded from www.norbrook.com. Norbrook also offers an iPhone App through which users can access essential product information including pharmaceutical presentation, uses, dosage and administration, withdrawal periods, contraindications & warnings and pharmaceutical precautions.
Animalcare has announced that Buprecare buprenorphine single dose ampoules are now back in stock and ready to order from all veterinary wholesalers.
Production of the product had ceased in July 2011, when the company's previous manufacturer closed its sterile production unit.
Animalcare says that since then, it has been working to identify a reliable, high quality manufacturer which will be able to meet demand. The company has now signed a new contract with a German company which operates a substantial sterile injectables manufacturing facility in France. This facility is approved to manufacture Buprecare single dose ampoules and has produced, tested, quality assured and shipped its first batches.
Stephen Wildridge, CEO of Animalcare Group plc, said: “It was very disappointing to lose our marketing leading product Buprecare ampoules so abruptly. However after some excellent work from the Animalcare team in identifying and working with a very competent manufacturer we are now back in a market that has been eagerly awaiting our return and with a supplier that puts us in an even stronger position. It’s a very good way to start 2013.”
Available in the familiar 5 x 1ml pack, the Buprecare single dose ampoules now have a ‘one-point-cut’ design giving greater assurance of a clean ‘snap’ when opening the ampoule, enhancing the safety of the user.
Additional support is also now available to veterinary practices that purchase Buprecare ampoules or multidose vials, including CPD pain management talks and a peer-reviewed pain assessment chart.
Stone Lion Veterinary Hospital, a first opinion and referral practice in Wimbledon, has announced that European Specialist in Veterinary Neurology Dr Sergio Rodenas, DVM DipECVN has joined the team to work alongside the Hospital's existing Veterinary Neurologist Dr Clare Rusbridge BVMS PhD DipECVN MRCVS RCVS and European Specialist in Veterinary Neurology.
The practice says that this will allow it to offer a full neurology referral service five days a week.
Sergio joins Stone Lion from his current post as Clinical Instructor in Neurology and Neurosurgery at the Veterinary College, St Hyacinthe at the University of Montreal. Before moving to Canada, he worked at the Southern Counties Veterinary Specialist (SCVS), a small animal specialist referral practice in Ringwood, Hampshire. He qualified at the Veterinary School, University of Extremadura, Spain, in 1996 and has also worked in both Spain and France.
The Stone Lion Veterinary Hospital is part of the Goddard Veterinary Group. It offers referrals in neurology, ophthalmology and physiotherapy. The Neurology Referral Practice is run by Clare Rusbridge and was established in 1997. She said: "Neurology is our busiest referral practice, drawing patients from across the South East of England and sometimes further afield. We see it as a growth area and wanted to offer our clients a five day a week service to make it easier for them to come to us. Sergio's experience especially in spinal surgery will be a huge asset to us and will enable us to meet this goal. We're delighted to welcome him."
Sergio added: "I am delighted to join the Neurology Service at the Stone Lion Veterinary Hospital. The facilities, team and professionalism of the staff and the track record of the Goddard Veterinary Group will make an excellent environment in which to practice small animal Neurology at the highest level and to offer the best care to patients."
The Stone Lion Veterinary Hospital can be contacted on 020 8946 4228.
Royal Canin has announced the winner of its second annual Weigh In Club initiative: a 32kg 12 year old Beagle called Amber that lost 12.5kg, or 39% of her bodyweight.
The dog lost weight with the help of Veterinary Nurse Gabby Taylor from Wilson Vet Group in Bishop Auckland, and won a year's supply of Royal Canin food along with £500 of gift vouchers for her owner. Gabby also won £500 of vouchers for her efforts, as well as £1000 of equipment vouchers for her practice.
Gabby said: "Amber was referred to my weight clinic and we quickly started her on Royal Canin's Satiety Support diet. Over the course of six months, Amber lost weight healthily and reached her target weight of 19.5kg, making her a much happier dog."
117 dogs took part in the initiative, with the 12 finalists invited to appear in a Royal Canin 2013 'Weigh In Club Winners' calendar.
The competition, which is due to be repeated in 2013, was open to all vet practices which run weight clinics and use Royal Canin 'Obesity Management' and 'Satiety Support' diets as part of weight loss programmes run by Veterinary Nurses.
Ian Williams BVSc MRCVS, Royal Canin's Veterinary Support Manager, said: "With canine and feline obesity on the increase, Veterinary Nurses have an important role to play in educating pet owners and supporting the weight loss process. Choosing the right nutrition for the individual pet is a key part of a successful weight management programme, along with a tailored exercise plan, regular monitoring and commitment from the owner."
For more information about Royal Canin's diets, call the company's veterinary helpline on 0800 717800 or visit www.royalcanin.co.uk
The first issue of the online European Journal of Companion Animal Practitioners (EJCAP) has gone online.
In the issue, which is available exclusively to members of the Federation of European Companion Animal Veterinary Associations (FECAVA), several top European experts on diagnostic imaging present their 'tips and tricks' on radiographic, arthroscopic and ultrasound examination of selected joints and abdominal organs. It also provides an insight into the newer tools of CT and MRI to show how these can help to diagnose some more elusive conditions.
In the issue, you can test your knowledge and watch 'how to' videos, interactive slideshows and dynamic CT scans.
Articles include:
The issue also features book reviews, global and European updates and FECAVA news, with the new poster on the prevention of antibiotic resistance, and a video message from the Russian FECAVA Director Ilya Serada.
If you'd like to register for membership of the FECAVA, visit: www.fecava.org/ejcap and follow the instructions. Once registered and logged in, all EJCAP online and previous print volumes of EJCAP (available in pdf) can be accessed directly.
FECAVA is supported by MSD Animal Health, Hills Pet Nutrition and Elanco Animal Health.